Delivery Order SPE2DB20D3101-SPE2DB25FRUR5
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Paxlovid 300-100 mg dose packs in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $20,945.82 and is scheduled for completion by September 9, 2025. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99...
- The Defense Logistics Agency awarded a delivery order valued at $7,480.65 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Paxlovid 300/150-100mg tablets for severe cases. This firm fixed-price delivery order, with an ultimate completion date of September 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999 through December 2026. The contract was...
- The Defense Logistics Agency awarded a delivery order valued at $3,184.92 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Paxlovid 300/150-100mg tablets designated for severe cases. This is a firm fixed-price, competitively awarded delivery order with a completion date of September 2, 2025, with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, under a firm fixed-price contract with a ceiling value of $192,058.56. This non-set-aside delivery order is scheduled for ultimate completion by September 9, 2025, and will be performed at the company's Corporate Office in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $12,279.88 to AmerisourceBergen Drug Corp on August 25, 2025, with completion targeted for August 26, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the pharmaceutical distributor for medical supplies to support federal healthcare procurement needs. The work will be performed at AmerisourceBergen's corporate office location in...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $5,324.08 to AmerisourceBergen Drug Corp on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order, issued without set-aside restrictions, represents a competitively awarded contract for pharmaceutical products and medical supplies supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's Corporate Office...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for pharmaceutical and medical supplies with a ceiling value of $2,819.28. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 25, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this award. This delivery order is issued...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a delivery order valued at $28,028.00 to AmerisourceBergen Drug Corp on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is to be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,257.70 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The contract follows a competitive procurement process, consistent with AmerisourceBergen's established...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 1, 2025, for pharmaceutical and medical supply products valued at $41,277.84. This firm fixed-price delivery order, which represents a child contract under a larger indefinite delivery vehicle, is scheduled for completion by September 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract was awarded...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUR5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Paxlovid 300-100 mg dose packs in quantities of 30 units. This competitively awarded, firm fixed-price delivery order carries a ceiling value of approximately $8,976.78 and is scheduled for completion by September 9, 2025. The contract utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999.00 global pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a broad range of pharmaceuticals and medical supplies to support military and veteran healthcare systems. The parent IDC enables the company to fulfill diverse medical requirements across multiple therapeutic domains, supporting customers including the Defense Health Agency and U.S. Coast Guard through a flexible contract structure designed to sustain critical pharmaceutical availability for defense operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.0k | 9/8/25 |